SCHEMBL31387684

SCHEMBL31387684

CCC(=O)Nc1ccc(Br)c(Cl)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR1 P25024 2/20 0.46
CXCR2 P25025 2/20 0.46
ALDH1A1 P00352 6/20 0.44
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
MAPT P10636 4/20 0.42
LMNA P02545 2/20 0.42
PKM P14618 1/20 0.42
MAPK1 P28482 1/20 0.42
CCR6 P51684 1/20 0.42
MCL1 Q07820 1/20 0.42
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
HTT P42858 2/20 0.42
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21631657 1.00 CXCR1 (0.46) CXCR1CXCR2ALDH1A1KMT2AMEN1
SCHEMBL31387781 0.83 TSHR (0.44) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL21631612 0.83 TSHR (0.44) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL21631387 0.81 RXFP1 (0.53) CXCR1CXCR2ALDH1A1KDM4EMAPT
SCHEMBL31387660 0.81 RXFP1 (0.53) CXCR1CXCR2ALDH1A1KDM4EMAPT
SCHEMBL1708569 0.75 MEN1 (0.60) CXCR2ALDH1A1KMT2AMEN1KDM4E
SCHEMBL20449077 0.74 SMN1; SMN2 (0.44) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL12535510 0.73 MEN1 (0.54) CXCR2ALDH1A1KMT2AMEN1KDM4E
SCHEMBL11576411 0.73 CYP3A4 (0.54) CXCR2ALDH1A1KMT2AMEN1KDM4E
SCHEMBL12106916 0.71 TSHR (0.46) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112513050-B Heterocyclic compounds which inhibit SHP2 activity 大鹏药品工业株式会社 2024-12-20 CN disclosed